Baxter International Inc. (NYSE:BAX) is expected to report third quarter earnings results, before market open, on Thursday 29th October 2020.
Analysts polled by Thomson Reuters anticipate third quarter income of $ 0.73 per share.
Looking ahead, the full year income are expected at $ 3.06 per share on the revenues of $ 11415.70 million.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 11,248.00 million ~ $ 11,476.00 million, where as bottomline are predicted in a range of $ 3.00 ~ $ 3.10 per share
Click Here For More Historical Outlooks Of Baxter International Inc.
Previous Quarter Performance
Baxter International Inc. unfold income for the second quarter of $ 0.64 per share, from the revenue of $ 2,718.00 million. The quarterly earnings contracted 23.81 percent while revenues decreased 4.30 percent compared with the same quarter last year.
According to street consensus, BAX was expected to report 2Q20 income of $ 0.71 per share from revenue of $ 2865.68 million. The bottom line results missed street analysts by $ 0.07 or 9.86 percent, at the same time, top line results fell short of analysts by $ 147.68 million or 5.15 percent.
Stock Performance
Shares of Baxter International Inc. traded low $ -2.47 or -3.06 percent on Wednesday, reaching $ 78.15 with volume of 2.43 million shares. Baxter International Inc. has traded high as $ 79.94 and has cracked $ 78.11 on the downward trend
According to the previous trading day, closing price of $ 78.15, representing a 16.67 % increase from the 52 week low of $ 69.10 and a 15.31 % decrease over the 52 week high of $ 95.19.
The company has a market capital of $ 39.56 billion and is part of the Healthcare sector and Medical Instruments & Supplies industry.
Conference Call
Baxter International Inc. will be hosting a conference call at 8:30 AM eastern time on 29th October 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.baxter.com
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies.
